RWA Wealth Partners LLC Has $8.84 Million Stake in McKesson Corporation $MCK

RWA Wealth Partners LLC raised its stake in McKesson Corporation (NYSE:MCK) by 956.1% during the third quarter, HoldingsChannel.com reports. The fund owned 11,438 shares of the company’s stock after acquiring an additional 10,355 shares during the quarter. RWA Wealth Partners LLC’s holdings in McKesson were worth $8,836,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of McKesson by 2.0% in the 2nd quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company’s stock valued at $8,846,186,000 after purchasing an additional 232,286 shares in the last quarter. Geode Capital Management LLC boosted its position in McKesson by 4.1% in the second quarter. Geode Capital Management LLC now owns 2,820,724 shares of the company’s stock valued at $2,057,065,000 after buying an additional 112,224 shares in the last quarter. Alliancebernstein L.P. grew its stake in McKesson by 150.4% during the second quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock worth $1,661,956,000 after buying an additional 1,362,386 shares during the last quarter. Norges Bank acquired a new stake in shares of McKesson during the second quarter worth approximately $1,346,661,000. Finally, Arrowstreet Capital Limited Partnership increased its holdings in McKesson by 56.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock valued at $906,109,000 after purchasing an additional 446,060 shares in the last quarter. 85.07% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, EVP Leann B. Smith sold 190 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president directly owned 2,989 shares in the company, valued at $2,824,605. This trade represents a 5.98% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This represents a 10.85% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 1,143 shares of company stock valued at $1,046,070. Insiders own 0.08% of the company’s stock.

McKesson Stock Performance

MCK opened at $962.65 on Thursday. The company has a fifty day moving average price of $862.22 and a two-hundred day moving average price of $802.17. The firm has a market capitalization of $117.91 billion, a PE ratio of 27.69, a P/E/G ratio of 1.54 and a beta of 0.40. McKesson Corporation has a 52 week low of $619.48 and a 52 week high of $971.93.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter in the prior year, the business posted $8.03 EPS. The firm’s quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on MCK. Barclays increased their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a report on Wednesday, February 18th. Wells Fargo & Company raised their price target on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Wall Street Zen cut shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Zacks Research lowered McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Finally, Robert W. Baird set a $968.00 target price on McKesson in a research note on Wednesday, January 14th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $943.50.

McKesson News Roundup

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Large institutional inflows are cited as a key driver behind the stock’s rally, suggesting continued demand from “big money” managers supporting higher valuations. Read More.
• Positive Sentiment: Barclays raised its price target to $1,050 (from $960) and kept an Overweight rating, signaling analyst conviction that shares should remain in favor — this helps push buyers toward the stock. Read More.
• Positive Sentiment: Recent quarterly results beat estimates and McKesson set FY2026 EPS guidance (38.80–39.20), which underpins the bullish analyst revisions and investor inflows. Read More.
• Neutral Sentiment: Industry research lists McKesson among vendors in an expanding Radiology Information Systems market — a longer-term market opportunity but not an immediate stock catalyst. Read More.
• Neutral Sentiment: Brokerage coverage remains skewed to Buy/Outperform (consensus “Moderate Buy”), which supports sentiment but leaves limited immediate upside unless fundamentals surprise further. Read More.
• Negative Sentiment: Faruqi & Faruqi launched a review of McKesson’s proposed share issuance and board conduct, raising governance and dilution concerns that could pressure the stock if the issuance proceeds or litigation follows. Read More.
• Negative Sentiment: An exec director sold ~349 shares (~$328k), a disclosed insider sale that investors may view as minor profit-taking but still worth noting amid governance scrutiny. Read More.
• Negative Sentiment: Some analysts/commentaries (e.g., Seeking Alpha) argue upside could be limited from current levels despite strong results, suggesting some investors may be taking profits. Read More.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.